Natixis Advisors’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
UCFA
MC
WA
Natixis Advisors's RGEN Position: Q2 2026 in Review
Natixis Advisors reduced its Repligen (RGEN) stake by 5.1% in Q2 2026, selling an estimated $176K and leaving 26,804 shares worth $3.66M. The position accounts for ﹤0.01% of the portfolio, ranked #1017.
Natixis Advisors first reported a position in RGEN in Q3 2021 and has held it in 20 quarters since. The position peaked at $41.6M in Q3 2021. 481 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.
- Natixis Advisors held 26,804 shares of Repligen worth $3.66M as of Q2 2026.
- Natixis Advisors sold 1,429 Repligen shares in Q2 2026, an estimated $176K.
- Repligen made up ﹤0.01% of Natixis Advisors's portfolio in Q2 2026, its #1017 holding.
- Natixis Advisors first reported a position in Repligen in Q3 2021 and has held it in 20 quarters since.
- Natixis Advisors's Repligen position peaked at $41.6M in Q3 2021.
- 481 funds tracked by Wall St. Rank held Repligen as of Q2 2026.
Based on Natixis Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.